1. World Health Organization; International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation [Internet]. Geneva: World Health Organization; 2006 [cited 2021 May 5]. Available from:
https://apps.who.int/iris/handle/10665/43588
8. Barry E, Roberts S, Oke J, Vijayaraghavan S, Normansell R, Greenhalgh T. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions. BMJ 2017;356:i6538.
10. Ramachandran A, Snehalatha C, Ma RC. Diabetes in South-East Asia: an update. Diabetes Res Clin Pract 2014;103:231-7.
11. Wan Nazaimoon WM, Md Isa SH, Wan Mohamad WB, Khir AS, Kamaruddin NA, Kamarul IM, et al. Prevalence of diabetes in Malaysia and usefulness of HbA1c as a diagnostic criterion. Diabet Med 2013;30:825-8.
12. Centers for Disease Control and Prevention. Prediabetes: your chance to prevent type 2 diabetes [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2021 [cited 2021 May 5]. Available from:
https://www.cdc.gov/diabetes/basics/prediabetes.html
14. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007;30:753-9.
15. Forouhi NG, Luan J, Hennings S, Wareham NJ. Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000. Diabet Med 2007;24:200-7.
17. Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 2007;78:305-12.
18. Keck JW, Thomas AR, Hieronymus L, Roper KL. Prediabetes knowledge, attitudes, and practices at an academic family medicine practice. J Am Board Fam Med 2019;32:505-12.
19. Mainous AG 3rd, Schatz DA. Is it time to prioritize diabetes prevention in practice? J Am Board Fam Med 2019;32:457-9.
21. Lopez-Jaramillo P, Sanchez RA, Diaz M, Cobos L, Bryce A, Parra Carrillo JZ, et al. Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome. J Hypertens 2013;31:223-38.
22. Garber AJ, Handelsman Y, Einhorn D, Bergman DA, Bloomgarden ZT, Fonseca V, et al. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin?: a consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract 2008;14:933-46.
26. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm: 2018 executive summary. Endocr Pract 2018;24:91-120.
27. Farr OM, Mantzoros CS. Treating prediabetes in the obese: are GLP-1 analogues the answer? Lancet 2017;389:1371-2.
28. Siu AL, U S Preventive Services Task Force. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2015;163:861-8.
29. Spencer Bonilla G, Rodriguez-Gutierrez R, Montori VM. What we don’t talk about when we talk about preventing type 2 diabetes-addressing socioeconomic disadvantage. JAMA Intern Med 2016;176:1053-4.
32. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm: 2017 executive summary. Endocr Pract 2017;23:207-38.
38. Sjostrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H, et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012;307:56-65.
39. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-93.
40. Garcia-Huidobro D, Mendenhall T. Family oriented care: opportunities for health promotion and disease prevention. J Fam Med Dis Prev 2015;1:2.
41. Institute for Patient and Family-Centered Care [Internet]. McLean (VA): Institute for Patient and Family-Centered Care; [date unknown] [cited 2021 May 6]. Available from:
https://www.ipfcc.org/
43. Weihs K, Fisher L, Baird M. Families, health, and behavior: a section of the commissioned report by the Committee on Health and Behavior: Research, Practice, and Policy Division of Neuroscience and Behavioral Health and Division of Health Promotion and Disease Prevention Institute of Medicine, National Academy of Sciences. Fam Syst Health 2002;20:7-46.
44. Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 2002;25:2165-71.
45. Martire LM. The “relative” efficacy of involving family in psychosocial interventions for chronic illness: are there added benefits to patients and family members? Fam Syst Health 2005;23:312-28.
47. Martire LM, Lustig AP, Schulz R, Miller GE, Helgeson VS. Is it beneficial to involve a family member?: a meta-analysis of psychosocial interventions for chronic illness. Health Psychol 2004;23:599-611.
51. Lubsen JR. The role of family functioning in a family-based diabetes prevention program [Internet]. New Haven (CT): Yale University School of Medicine; 2013 [cited 2021 May 18]. Available from:
http://elischolar.library.yale.edu/ymtdl/1818
52. Epstein NB, Bishop DS, Levin S. The McMaster model of family functioning. J Marital Fam Ther 1978;4:19-31.
53. Olson DH, Sprenkle DH, Russell CS. Circumplex model of marital and family system: I. Cohesion and adaptability dimensions, family types, and clinical applications. Fam Process 1979;18:3-28.
54. Smilkstein G, Ashworth C, Montano D. Validity and reliability of the family APGAR as a test of family function. J Fam Pract 1982;15:303-11.
55. Moos RH. Conceptual and empirical approaches to developing family-based assessment procedures: resolving the case of the Family Environment Scale. Fam Process 1990;29:199-211.
56. Skinner H, Steinhauer P, Sitarenios G. Family assessment measure (FAM) and process model of family functioning. J Fam Ther 2000;22:190-210.
57. van Esch SC, Cornel MC, Geelhoed-Duijvestijn PH, Snoek FJ. Family communication as strategy in diabetes prevention: an observational study in families with Dutch and Surinamese South-Asian ancestry. Patient Educ Couns 2012;87:23-9.
61. Pijl M, Timmermans DR, Claassen L, Janssens AC, Nijpels G, Dekker JM, et al. Impact of communicating familial risk of diabetes on illness perceptions and self-reported behavioral outcomes: a randomized controlled trial. Diabetes Care 2009;32:597-9.
64. Allen MP, Auld E, Logan R, Montes JH, Rosen S. Improving collaboration among health communication, health education, and health literacy. NAM Perspect 2017 Jul 10 [Epub].
https://doi.org/10.31478/201707c
66. Ali MK, Bullard KM, Gregg EW, Del Rio C. A cascade of care for diabetes in the United States: visualizing the gaps. Ann Intern Med 2014;161:681-9.
69. Anderson ZL, Scopelliti EM, Trompeter JM, Havrda DE. Management of prediabetes: a comparison of the treatment approaches utilized by a family practice clinic and an internal medicine/endocrinology practice. J Pharm Pract 2015;28:86-92.
70. Ono S, Ono Y, Matsui H, Yasunaga H. Impact of clinic follow-up visits on body weight control in people with prediabetes or diabetes mellitus: Japanese nonelderly cohort study. Fam Pract 2017;34:552-7.
71. Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, et al. American Association of Clinical Endocrinologists’ guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract 2012;18 Suppl 1:1-78.